17
Views
25
CrossRef citations to date
0
Altmetric
Original Article

Comparative Study of CA-50 (Time-Resolved Fluoroimmunoassay), Span-1, and CA19-9 in the Diagnosis of Pancreatic Cancer

, , , , , , & show all
Pages 787-797 | Received 02 Jul 1990, Accepted 14 Feb 1991, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Matti Eskelinen, Ulf Haglund. (1999) Developments in Serologic Detection of Human Pancreatic Adenocarcinoma. Scandinavian Journal of Gastroenterology 34:9, pages 833-844.
Read now
S. Kawa, M. Kato, H. Oguchi, G. L. Hsue, T. Kobayashi, T. Koiwai, M. Tokoo, S. Furuta, T. Ichikawa & M. Kanai. (1992) Clinical Evaluation of Pancreatic Cancer-Associated Mucin Expressing CA19-9, CA50, Span-1, Sialyl-SSEA-l, and Dupan-2. Scandinavian Journal of Gastroenterology 27:8, pages 635-643.
Read now
S. Kawa, M. Kato, H. Oguchi, T. Kobayashi, G. L. Hsue, T. Koiwai, Y. Aoki, S. Furuta & M. Kanai. (1991) Preparation and Partial Characterization of a Pancreatic Cancer-Associated Glycoprotein Expressing CA50. Scandinavian Journal of Gastroenterology 26:12, pages 1307-1318.
Read now

Articles from other publishers (22)

Eramah Ermiah, Mona Eddfair, Othman Abdulrahman, Mohamed Elfagieh, Abdalla Jebriel, Mona Al‑Sharif, Mourad Assidi & Abdelbaset Buhmeida. (2022) Prognostic value of serum CEA and CA19‑9 levels in pancreatic ductal adenocarcinoma. Molecular and Clinical Oncology 17:2.
Crossref
Andrii Khomiak, Marius Brunner, Maximilian Kordes, Stina Lindblad, Rainer Christoph Miksch, Daniel Öhlund & Ivonne Regel. (2020) Recent Discoveries of Diagnostic, Prognostic and Predictive Biomarkers for Pancreatic Cancer. Cancers 12:11, pages 3234.
Crossref
Yang Tang, Yidi Cui, Shufeng Zhang & Lijuan Zhang. 2019. Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part A. Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part A 121 140 .
Pengjiao Zeng, Hui Li, Yulong Chen, Haitao Pei & Lijuan Zhang. 2019. Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part A. Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part A 253 264 .
Lois A. Daamen, Vincent P. Groot, Hanne D. Heerkens, Martijn P.W. Intven, Hjalmar C. van Santvoort & I. Quintus Molenaar. (2018) Systematic review on the role of serum tumor markers in the detection of recurrent pancreatic cancer. HPB 20:4, pages 297-304.
Crossref
Brian B. Haab, Ying Huang, Seetharaman Balasenthil, Katie Partyka, Huiyuan Tang, Michelle Anderson, Peter Allen, Aaron Sasson, Herbert Zeh, Karen Kaul, Doron Kletter, Shaokui Ge, Marshall Bern, Richard Kwon, Ivan Blasutig, Sudhir Srivastava, Marsha L. Frazier, Subrata Sen, Michael A. Hollingsworth, Jo Ann Rinaudo, Ann M. Killary & Randall E. Brand. (2015) Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens. PLOS ONE 10:10, pages e0139049.
Crossref
Sudhir Singh, Kuntal Pal, Jessica Yadav, Huiyuan Tang, Katie Partyka, Doron Kletter, Peter Hsueh, Elliot Ensink, Birendra KC, Galen Hostetter, H. Eric Xu, Marshall Bern, David F. Smith, Anand S. Mehta, Randall Brand, Karsten Melcher & Brian B. Haab. (2015) Upregulation of Glycans Containing 3′ Fucose in a Subset of Pancreatic Cancers Uncovered Using Fusion-Tagged Lectins. Journal of Proteome Research 14:6, pages 2594-2605.
Crossref
Huiyuan Tang, Sudhir Singh, Katie Partyka, Doron Kletter, Peter Hsueh, Jessica Yadav, Elliot Ensink, Marshall Bern, Galen Hostetter, Douglas Hartman, Ying Huang, Randall E. Brand & Brian B. Haab. (2015) Glycan Motif Profiling Reveals Plasma Sialyl-Lewis X Elevations in Pancreatic Cancers That Are Negative for Sialyl-Lewis A *. Molecular & Cellular Proteomics 14:5, pages 1323-1333.
Crossref
Sukhwinder Kaur, Michael J Baine, Maneesh Jain, Aaron R Sasson & Surinder K Batra. (2012) Early diagnosis of pancreatic cancer: challenges and new developments. Biomarkers in Medicine 6:5, pages 597-612.
Crossref
Wataru Fukuda, Yasuhide Mitsumoto, Takahiro Mori, Seiji Shimizu & Takeshi Okanoue. (2012) Three cases of viral liver injury with a decrease in serum CA19-9 level after antiviral therapy. Kanzo 53:2, pages 109-116.
Crossref
Felix Rückert, Christian Pilarsky & Robert Grützmann. (2010) Serum Tumor Markers in Pancreatic Cancer—Recent Discoveries. Cancers 2:2, pages 1107-1124.
Crossref
Ying Chen, Guanzhen Yu, Dalie Ma, Canrong Ni & Minghua Zhu. (2009) Microadenocarcinoma of the pancreas. European Journal of Gastroenterology & Hepatology 21:12, pages 1373-1378.
Crossref
Liliane Benkoël, Jean-Paul Bernard, Marie-José Payan-Defais, Lydie Crescence, Cécile Franceschi, Mireille Delmas, Mehdi Ouaissi, Bernard Sastre, José Sahel, Anne-Marie Benoliel, Pierre Bongrand, Françoise Silvy, Laurent Gauthier, François Romagné, Dominique Lombardo & Eric Mas. (2009) Monoclonal antibody 16D10 to the COOH-terminal domain of the feto-acinar pancreatic protein targets pancreatic neoplastic tissues. Molecular Cancer Therapeutics 8:2, pages 282-291.
Crossref
Yasuji Arase, Fumitaka Suzuki, Yoshiyuki Suzuki, Norio Akuta, Masahiro Kobayashi, Yusuke Kawamura, Hiromi Yatsuji, Hitomi Sezaki, Tetsuya Hosaka, Miharu Hirakawa, Satoshi Saito, Kenji Ikeda & Hiromitsu Kumada. (2008) Hepatitis C virus enhances incidence of idiopathic pulmonary fibrosis. World Journal of Gastroenterology 14:38, pages 5880.
Crossref
Philippe Lévy. (2008) Adénocarcinome du pancréas : le dosage du CA 19-9 a-t-il un intérêt ?. La Presse Médicale 37:1, pages 88-94.
Crossref
K.S. Goonetilleke & A.K. Siriwardena. (2007) Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. European Journal of Surgical Oncology (EJSO) 33:3, pages 266-270.
Crossref
Laurence Panicot-Dubois, Muriel Aubert, Cécile Franceschi, Eric Mas, Françoise Silvy, Christian Crotte, Jean-Paul Bernard, Dominique Lombardo & Marie-Odile Sadoulet. (2004) Monoclonal Antibody 16D10 to the C-Terminal Domain of the Feto-Acinar Pancreatic Protein Binds to Membrane of Human Pancreatic Tumoral SOJ-6 Cells and Inhibits the Growth of Tumor Xenografts. Neoplasia 6:6, pages 713-724.
Crossref
L. Panicot, E. Mas, E. Pasqualini, M. Zerfaoui, D. Lombardo, M.-O. Sadoulet & A. El Battari. (1999) The formation of the oncofetal J28 glycotope involves core-2  6-N-acetylglucosaminyltransferase and a3/4-fucosyltransferase activities. Glycobiology 9:9, pages 935-946.
Crossref
Carlos Rollhauser & William Steinberg. 1998. Pancreatic Cancer. Pancreatic Cancer 137 156 .
Birger Plsson, Parvesh Masson & Åke Andrén-Sandberg. (1997) Tumour marker CA 50 levels compared to signs and symptoms in the diagnosis of pancreatic cancer. European Journal of Surgical Oncology (EJSO) 23:2, pages 151-156.
Crossref
M. Plebani, D. Basso, M.P. Panozzo, P. Fogar, G. Del Favero & R. Naccarato. (2018) Tumor Markers in the Diagnosis, Monitoring and Therapy of Pancreatic Cancer: State of the Art. The International Journal of Biological Markers 10:4, pages 189-199.
Crossref
Torben F. �rntoft & Einar Bech. (1995) Circulating blood group related carbohydrate antigens as tumour markers. Glycoconjugate Journal 12:3, pages 200-205.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.